119 related articles for article (PubMed ID: 23179004)
1. Same-day or historical ESR for disease activity score measurement: does it matter?
Brode S; Nisar MK; Ostör AJ
Clin Rheumatol; 2013 Feb; 32(2):261-5. PubMed ID: 23179004
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the disease activity score using the erythrocyte sedimentation rate and C-reactive protein levels in Koreans with rheumatoid arthritis.
Son KM; Kim SY; Lee SH; Yang CM; Seo YI; Kim HA
Int J Rheum Dis; 2016 Dec; 19(12):1278-1283. PubMed ID: 26200604
[TBL] [Abstract][Full Text] [Related]
3. Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis.
Kuriya B; Schieir O; Lin D; Xiong J; Pope J; Boire G; Haraoui B; Thorne JC; Tin D; Hitchon C; Jamal S; Keystone E; Bykerk VP;
Clin Exp Rheumatol; 2017; 35(5):799-803. PubMed ID: 28339365
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the DAS28-CRP and DAS28-ESR in patients with rheumatoid arthritis.
Sengul I; Akcay-Yalbuzdag S; Ince B; Goksel-Karatepe A; Kaya T
Int J Rheum Dis; 2015 Jul; 18(6):640-5. PubMed ID: 26013310
[TBL] [Abstract][Full Text] [Related]
5. The use of different methods for rapid determination of the ESR induces DAS28 misclassification in clinical practice.
van der Maas A; van den Ende CH; van Eerd J; Fransen J; den Broeder AA
Clin Exp Rheumatol; 2010; 28(4):477-82. PubMed ID: 20598225
[TBL] [Abstract][Full Text] [Related]
6. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan.
Matsui T; Kuga Y; Kaneko A; Nishino J; Eto Y; Chiba N; Yasuda M; Saisho K; Shimada K; Tohma S
Ann Rheum Dis; 2007 Sep; 66(9):1221-6. PubMed ID: 17369281
[TBL] [Abstract][Full Text] [Related]
7. A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial.
Moreland LW; O'Dell JR; Paulus HE; Curtis JR; Bathon JM; St Clair EW; Bridges SL; Zhang J; McVie T; Howard G; van der Heijde D; Cofield SS;
Arthritis Rheum; 2012 Sep; 64(9):2824-35. PubMed ID: 22508468
[TBL] [Abstract][Full Text] [Related]
8. The comparative responsiveness of the patient self-report questionnaires and composite disease indices for assessing rheumatoid arthritis activity in routine care.
Salaffi F; Ciapetti A; Gasparini S; Carotti M; Bombardieri S;
Clin Exp Rheumatol; 2012; 30(6):912-21. PubMed ID: 22935335
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the validity of the 28-joint disease activity score using erythrocyte sedimentation rate (DAS28-ESR) as a disease activity index of rheumatoid arthritis in the efficacy evaluation of 24-week treatment with tocilizumab: subanalysis of the SATORI study.
Nishimoto N; Takagi N
Mod Rheumatol; 2010 Dec; 20(6):539-47. PubMed ID: 20617358
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the disease activity score using erythrocyte sedimentation rate and C-reactive protein in African Americans with rheumatoid arthritis.
Tamhane A; Redden DT; McGwin G; Brown EE; Westfall AO; Reynolds RJ; Hughes LB; Conn DL; Callahan LF; Jonas BL; Smith EA; Brasington RD; Moreland LW; Bridges SL
J Rheumatol; 2013 Nov; 40(11):1812-22. PubMed ID: 23950187
[TBL] [Abstract][Full Text] [Related]
11. Are the C-reactive protein values and erythrocyte sedimentation rate equivalent when estimating the 28-joint disease activity score in rheumatoid arthritis?
Castrejón I; Ortiz AM; García-Vicuña R; Lopez-Bote JP; Humbría A; Carmona L; Gonzalez-Alvaro I
Clin Exp Rheumatol; 2008; 26(5):769-75. PubMed ID: 19032807
[TBL] [Abstract][Full Text] [Related]
12. How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index?
Fleischmann R; van der Heijde D; Koenig AS; Pedersen R; Szumski A; Marshall L; Bananis E
Ann Rheum Dis; 2015 Jun; 74(6):1132-7. PubMed ID: 25143522
[TBL] [Abstract][Full Text] [Related]
13. Prospective Comparison of Angiogenesis-Specific 68Ga-RGD2 PET/CT Imaging Parameters and DAS28-ESR in Rheumatoid Arthritis.
Kavanal AJ; Bhattacharya A; Sharma A; Shukla J; Chattopadhyay A; M B A; Sharma V; Vatsa R; Rana N; Kaur G; Mittal BR
Clin Nucl Med; 2021 Jul; 46(7):556-561. PubMed ID: 33782288
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of disease activity indices in Korean patients with rheumatoid arthritis.
Park SY; Lee H; Cho SK; Choi CB; Sung YK; Bae SC
Rheumatol Int; 2012 Feb; 32(2):545-9. PubMed ID: 21305296
[TBL] [Abstract][Full Text] [Related]
15. Routine Assessment of Patient Index Data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practice.
Boone NW; Sepriano A; van der Kuy PH; Janknegt R; Peeters R; Landewé RBM
RMD Open; 2019; 5(2):e001050. PubMed ID: 31908842
[TBL] [Abstract][Full Text] [Related]
16. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate.
Wells G; Becker JC; Teng J; Dougados M; Schiff M; Smolen J; Aletaha D; van Riel PL
Ann Rheum Dis; 2009 Jun; 68(6):954-60. PubMed ID: 18490431
[TBL] [Abstract][Full Text] [Related]
17. Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial.
Dale J; Stirling A; Zhang R; Purves D; Foley J; Sambrook M; Conaghan PG; van der Heijde D; McConnachie A; McInnes IB; Porter D
Ann Rheum Dis; 2016 Jun; 75(6):1043-50. PubMed ID: 27026689
[TBL] [Abstract][Full Text] [Related]
18. Effect of human immunodeficiency virus infection on disease activity in rheumatoid arthritis: a retrospective study in South Africans.
Tarr G; Makda M; Musenge E; Tikly M
J Rheumatol; 2014 Aug; 41(8):1645-9. PubMed ID: 25028384
[TBL] [Abstract][Full Text] [Related]
19. Interchangeability of 28-joint disease activity scores using the erythrocyte sedimentation rate or the C-reactive protein as inflammatory marker.
Siemons L; Vonkeman HE; ten Klooster PM; van Riel PL; van de Laar MA
Clin Rheumatol; 2014 Jun; 33(6):783-9. PubMed ID: 24562719
[TBL] [Abstract][Full Text] [Related]
20. Relationship between neutrophil-lymphocyte, platelet-lymphocyte ratio and disease activity in rheumatoid arthritis treated with rituximab.
Sargin G; Senturk T; Yavasoglu I; Kose R
Int J Rheum Dis; 2018 Dec; 21(12):2122-2127. PubMed ID: 30338636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
